Tofflon Science and Technology Group Co., Ltd. researches, develops, produces, sells, and services pharmaceutical equipment in China and internationally. Its offerings include cell technology, complex preparation, injection, and OSD laboratory research; instruments for cell therapy and nucleic acid drugs, laboratory facilities, and table reactors; single-use technologies such as bioreactors, liquid distribution systems, sterile bags, process chromatography, and membrane filtration systems; and cryopreservation systems for seeds and biological samples, as well as freeze-thaw systems for biological stock solutions. The company also provides culture media, bioreactors, fermentation systems, cell factories, perfusion and complementary systems, preparation systems, separation and purification systems, resins, API, cleaning and sterilization, filling lines, OSD products and services, freeze-drying systems, packaging systems, isolator and inspection systems, and engineering services. Formerly known as Shanghai Tofflon Science and Technology Co., Ltd., the company was founded in 1993 and is headquartered in Shanghai, China.